Across TCGA patient cohorts, CCDC183 mutation is significantly associated with the RNA expression of many other genes, with 715 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CCDC183-associated genes across cancer lineages are TRAJ47, OR3B1P, and VTRNA2-2P. Each is linked with CCDC183 in more than 2 cancer types. Because this analysis shows association rather than direction, both CCDC183-to-partner and partner-to-CCDC183 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CCDC183→partner) and Y-score (partner→CCDC183) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BRCA	TRAJ47 →	+0.582	+5.062	.003	.002	3	3
LUAD	OR3B1P →	+0.042	+4.303	<.001	.009	3	2
CESC	VTRNA2-2P →	+0.366	+4.601	.001	.004	3	2
BLCA	RN7SL66P →	+0.154	+3.762	<.001	.003	3	2
COAD	MIR212 →	+0.329	+4.537	<.001	.006	3	2
LUAD	RNA5SP52 →	+0.312	+3.855	.002	.006	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 715 associations by consensus.

Exploration

CCDC183 survival (RNA) · tumor vs normal (RNA) · all CCDC183 data types